We observed significantly higher levels of exhaustion (ICOS, TIM3, CTLA4, PD1, LAG3, TIGIT) and activation (TNFSR9, CD69, CD25) markers for clonotypes restricted to the tumor (Figure 5H). This evidence concerns the gene CD69 and neoplasm.